Patents by Inventor Larry Hamel

Larry Hamel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 10507180
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: December 17, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20190125659
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 5, 2018
    Publication date: May 2, 2019
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 10245228
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: April 2, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20180161270
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: July 20, 2017
    Publication date: June 14, 2018
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 9744129
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: August 29, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20160213606
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: April 6, 2016
    Publication date: July 28, 2016
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 9320710
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: April 26, 2016
    Assignee: AcelRX Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Methods for administering small volume oral transmucosal dosage forms using a dispensing device
    Patent number: 9289583
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 22, 2016
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew I Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Larry Hamel
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20150105424
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 16, 2015
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
    Patent number: 8945592
    Abstract: Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: February 3, 2015
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Shamim Pushpala, Larry Hamel, Stelios Tzannis, Evangeline Cruz
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 8865743
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: October 21, 2014
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine, Charles Rampersaud, Bruce Edwards
  • Bioadhesive drug formulations for oral transmucosal delivery
    Patent number: 8865211
    Abstract: Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral mucosa, and methods for using the same.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: October 21, 2014
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Stelios Tzannis, Larry Hamel, Pamela Palmer, Thomas Schreck, Andrew I. Poutiatine
  • Small-volume oral transmucosal dosage forms
    Patent number: 8778394
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: July 15, 2014
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
    Patent number: 8778393
    Abstract: Compositions, methods and systems for administration of small volume sufentanil-containing drug dosage forms to the oral mucosa of a subject are disclosed.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: July 15, 2014
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine, Charles Rampersaud, Bruce Edwards
  • Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms
    Patent number: 8499966
    Abstract: A method of administering small, bioadhesive drug tablets includes moving an end portion of a delivery member. A surface of the delivery member can be positioned to prevent movement of the drug tablet from a tablet cartridge channel to a delivery passage of a delivery device when the end portion of the delivery member is in a first stopped position. The end portion of the delivery member can be moved to a second position within the delivery passage such that the tablet cartridge channel is in communication with the delivery passage. The drug tablet can be conveyed into the delivery passage via the tablet cartridge channel. The end portion of the delivery member can be moved to a third position within the delivery passage to convey the drug tablet through an exit opening of the delivery device.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: August 6, 2013
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew I. Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Larry Hamel
  • SMALL-VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS
    Publication number: 20130165481
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Application
    Filed: July 30, 2012
    Publication date: June 27, 2013
    Applicant: ACELRX PHARMACEUTICALS, INC
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • BIOADHESIVE DRUG FORMULATIONS FOR ORAL TRANSMUCOSAL DELIVERY
    Publication number: 20130156842
    Abstract: Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral mucosa, and methods for using the same.
    Type: Application
    Filed: August 27, 2012
    Publication date: June 20, 2013
    Applicant: ACELRX PHARMACEUTICALS, INC.
    Inventors: Stelios Tzannis, Larry Hamel, Pamela Palmer, Thomas Schreck, Andrew I. Poutiatine
  • SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS CONTAINING SUFENTANIL FOR TREATMENT OF PAIN
    Publication number: 20130158074
    Abstract: Compositions, methods and systems for administration of small volume sufentanil-containing drug dosage forms to the oral mucosa of a subject are disclosed.
    Type: Application
    Filed: July 23, 2012
    Publication date: June 20, 2013
    Applicant: ACELRX PHARMACEUTICALS, INC
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine, Charles Rampersaud, Bruce Edwards
  • Bioadhesive drug formulations for oral transmucosal delivery
    Patent number: 8252328
    Abstract: Formulations for controlled delivery of oral transmucosal medications are provided. The formulations are characterized as hydrogel-forming or eroding-types which are bioadhesive and provide for controlled and sustained release of the medication such that enhanced bioavailability and efficacy is provided.
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: August 28, 2012
    Assignee: Acelrx Pharmaceuticals, Inc.
    Inventors: Stelios Tzannis, Pamela Palmer, Thomas Schreck, Larry Hamel, Andrew I. Poutiatine
  • Bioadhesive drug formulations for oral transmucosal delivery
    Patent number: 8252329
    Abstract: Bioadhesive drug formulations that adhere to an oral mucosal membrane of a subject are provided together with single dose applicators and devices for delivering the drug formulations to the oral mucosa, and methods for using the same.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: August 28, 2012
    Assignee: Acelrx Pharmaceuticals, Inc.
    Inventors: Stelios Tzannis, Larry Hamel, Pamela Palmer, Thomas Schreck, Andrew I. Poutiatine